Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 33273028.
- Also identified by DOI 10.1136/thoraxjnl-2020-216377 and PMC identifier 7716295.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study assessed symptoms and their determinants 1.5-6 months after symptom onset in non-hospitalised subjects with confirmed COVID-19 until 1 June 2020, in a geographically defined area. We invited 938 subjects; 451 (48%) responded. They reported less symptoms after 1.5-6 months than during COVID-19; median (IQR) 0 (0-2) versus 8 (6-11), respectively (p<0.001); 53% of women and 67% of men were symptom free, while 16% reported dyspnoea, 12% loss/disturbance of smell, and 10% loss/disturbance of taste. In multivariable analysis, having persistent symptoms was associated with the number of comorbidities and number of symptoms during the acute COVID-19 phase.
Medical subject headings
- COVID-19
- Dyspnea
- Olfaction Disorders
- Outpatients
- Pandemics
- Smell